Bryan J. Hall will be attending the 12th Annual International Bar Association (IBA) World Life Sciences Conference on June 3-5, 2026 in Lisbon, Portugal. The conference is co-hosted by the IBA Healthcare and Life Sciences Law Committee, the IBA Intellectual Property and Entertainment Law Committee and the IBA Technology Law Committee.
Subjects include:
- Hot topic roundtables
- Beyond borders: rewriting the rules of global pharma patent litigation
- AI and data rights in life sciences/health tech deals
- Clinical trials: current trends and perspectives at a global level
- Life sciences M&A in uncertain markets – earnouts, CVRs, contingent milestones, and IP-driven valuation mechanics/late-stage private financings and IPO alternatives (crossovers, structured preferred, PIPEs, ATMs and registered directs)
- What are the most challenging contractual issues when discussing licensing and other agreements with strategic partners?
- Preventive health and longevity: legal perspectives shaping the future of care
- Where will innovation go next? Global pharma strategies beyond the EU Pharmaceutical Package